文献速递类风湿关节炎

类风湿关节炎患者心血管风险管理仍不理想

Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

该研究评估了720例已确诊类风湿关节炎(RA)患者的10年心血管(CV)风险评分,并依据荷兰CV风险管理指南判断治疗不足情况。结果显示53%患者为高风险(≥20%),69%有预防性治疗指征,但其中42%治疗不充分、40%未治疗。结论认为RA人群CV风险管理仍面临重大挑战,亟需加强。

要点

  • 53%的RA患者10年CV风险为高风险(≥20%),9%已患心血管疾病。
  • 69%患者有降脂或降压预防治疗指征,其中42%治疗不充分、40%未治疗。
  • RA患者CV风险管理仍不理想,需提高认识和优化管理。

核心结论

  • 最佳CV风险管理仍是重大挑战,亟需提高认识和管理以降低RA人群高CV风险。

研究设计与样本

  • 研究纳入720例连续RA患者,其中375例来自Reade、345例来自Antonius医院,通过问卷评估人口学、CV危险因素和CVD患病率。
  • 依据荷兰CV风险管理指南计算10年CV风险评分,测量收缩压并从空腹血样测定胆固醇水平。

主要发现

  • 患者平均年龄59岁(s.d. 12),73%为女性。
  • 69%有预防性治疗(降胆固醇或降压药)指征,其中42%治疗不充分、40%完全未治疗。

关键数值与推荐

  • 治疗目标为收缩压≤140 mmHg和/或低密度脂蛋白≤2.5 mmol/l,未达标视为治疗不充分。
  • 患者分为四组:有治疗指征但未治疗、治疗不充分未达标、治疗充分、无需治疗。

临床怎么用

  • 对RA患者应常规评估10年CV风险评分并监测血压和血脂。
  • 有预防治疗指征者需确保治疗充分达标,避免治疗不足或未治疗。
  • 提高医生和患者对RA合并高CV风险的认识,优化风险管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the 10-year cardiovascular (CV) risk score and to identify treatment and undertreatment of CV risk factors in patients with established RA. METHODS: Demographics, CV risk factors and prevalence of cardiovascular disease (CVD) were assessed by questionnaire. To calculate the 10-year CV risk score according to the Dutch CV risk management guideline, systolic blood pressure was measured and cholesterol levels were determined from fasting blood samples. Patients were categorized into four groups: indication for treatment but not treated; inadequately treated, so not meeting goals (systolic blood pressure ⩽140 mmHg and/or low-density lipoprotein ⩽2.5 mmol/l); adequately treated; or no treatment necessary. RESULTS: A total of 720 consecutive RA patients were included, 375 from Reade and 345 from the Antonius Hospital. The mean age of patients was 59 years (s.d. 12) and 73% were female. Seventeen per cent of the patients had a low 10-year CV risk (<10%), 21% had an intermediate risk (10-19%), 53% a high risk (⩾20%) and 9% had CVD. In total, 69% had an indication for preventive treatment (cholesterol-lowering or antihypertensive drugs). Of those, 42% received inadequate treatment and 40% received no treatment at all. CONCLUSION: Optimal CV risk management remains a major challenge and better awareness and management are urgently needed to reduce the high risk of CVD in the RA population.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. van den Oever IAM, Heslinga M, Griep EN, et al. Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project. Rheumatology (Oxford). 2017. PMID: 28199724. doi:10.1093/rheumatology/kew497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。